|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
43
|
Sun, 8/2/09, 4:00 PM - 5:50 PM | CC-102B |
| Issues and Challenges in Dichotomizing Continuous Variables in Clinical Trials - Invited - Papers | ||
|
Biopharmaceutical Section, International Chinese Statistical Association |
||
| Organizer(s): Steven Snapinn, Amgen, Inc. | ||
| Chair(s): Tom Uryniak, AstraZeneca Pharmaceuticals | ||
| 4:05 PM |
Issues and Challenges in Dichotomizing Continuous Variables in Clinical Trials —  Qi Jiang, Amgen, Inc.; Ivan S.F. Chan, Merck & Co., Inc.
|
|
| 4:30 PM |
The Use of Responder Analyses in Regulatory Guidance and Professional Society Guidelines — Leonard Oppenheimer, Johnson & Johnson PRD; Zhongxin (John) Zhang, Johnson & Johnson PRD
|
|
| 4:55 PM |
The Impact of Dichotomization on the Power to Assess a Treatment Effect — Valerii V. Fedorov, GlaxoSmithKline; Chi-hse Teng, Amylin Pharmaceutical Inc.
|
|
| 5:20 PM | Disc: Lisa M. LaVange, The University of North Carolina at Chapel Hill | |
| 5:40 PM | Floor Discussion | |
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |